These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 29364302

  • 1. Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats.
    Martínez R, Kapravelou G, Donaire A, Lopez-Chaves C, Arrebola F, Galisteo M, Cantarero S, Aranda P, Porres JM, López-Jurado M.
    Food Funct; 2018 Feb 21; 9(2):830-850. PubMed ID: 29364302
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.
    Decara JM, Pavón FJ, Suárez J, Romero-Cuevas M, Baixeras E, Vázquez M, Rivera P, Gavito AL, Almeida B, Joglar J, de la Torre R, Rodríguez de Fonseca F, Serrano A.
    Dis Model Mech; 2015 Oct 01; 8(10):1213-25. PubMed ID: 26438694
    [Abstract] [Full Text] [Related]

  • 5. The combined treatment with lentil protein hydrolysate and a mixed training protocol is an efficient lifestyle intervention to manage cardiovascular and renal alterations in obese Zucker rats.
    Porres JM, Constantino J, Kapravelou G, Lopez-Chaves C, Galisteo M, Aranda P, López-Jurado M, Martínez R.
    Eur J Nutr; 2020 Dec 01; 59(8):3473-3490. PubMed ID: 32030473
    [Abstract] [Full Text] [Related]

  • 6. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I, Sánchez-González C, Martínez R, López-Chaves C, Porres JM, Aranda P, Llopis J, Galisteo M, Zarzuelo A, Errami M, López-Jurado M.
    Metabolism; 2013 Nov 01; 62(11):1641-50. PubMed ID: 23932644
    [Abstract] [Full Text] [Related]

  • 7. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS, Hur HJ, Kim SH, Park SJ, Hong MJ, Sung MJ, Kwon DY, Kim MS.
    Mol Nutr Food Res; 2016 Sep 01; 60(9):1944-55. PubMed ID: 27145114
    [Abstract] [Full Text] [Related]

  • 8. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
    Tan Y, Kim J, Cheng J, Ong M, Lao WG, Jin XL, Lin YG, Xiao L, Zhu XQ, Qu XQ.
    World J Gastroenterol; 2017 Jun 07; 23(21):3805-3814. PubMed ID: 28638220
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial.
    Khoo J, Hsiang J, Taneja R, Law NM, Ang TL.
    Diabetes Obes Metab; 2017 Dec 07; 19(12):1814-1817. PubMed ID: 28503750
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S, Soares E Silva A, Gomes F, Ribeiro E, Oliveira W, Oliveira A, Lima I, Lima MDC, Pitta I, Peixoto C.
    Eur J Pharmacol; 2016 Oct 05; 788():306-314. PubMed ID: 27349145
    [Abstract] [Full Text] [Related]

  • 16. Dietary walnut oil modulates liver steatosis in the obese Zucker rat.
    Fink A, Rüfer CE, Le Grandois J, Roth A, Aoude-Werner D, Marchioni E, Bub A, Barth SW.
    Eur J Nutr; 2014 Oct 05; 53(2):645-60. PubMed ID: 23942585
    [Abstract] [Full Text] [Related]

  • 17. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
    Barbosa-da-Silva S, Souza-Mello V, Magliano DC, Marinho Tde S, Aguila MB, Mandarim-de-Lacerda CA.
    Life Sci; 2015 Apr 15; 127():73-81. PubMed ID: 25748419
    [Abstract] [Full Text] [Related]

  • 18. Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response.
    Yang Q, Shu F, Gong J, Ding P, Cheng R, Li J, Tong R, Ding L, Sun H, Huang W, Wang Z, Yang L.
    J Ethnopharmacol; 2020 Jun 12; 255():112556. PubMed ID: 31926984
    [Abstract] [Full Text] [Related]

  • 19. A combined healthy strategy for successful weight loss, weight maintenance and improvement of hepatic lipid metabolism.
    Martínez R, López-Trinidad LM, Kapravelou G, Arrebola F, Galisteo M, Aranda P, Porres JM, López-Jurado M.
    J Nutr Biochem; 2020 Nov 12; 85():108456. PubMed ID: 32810797
    [Abstract] [Full Text] [Related]

  • 20. α-Linolenic acid supplementation and exercise training reveal independent and additive responses on hepatic lipid accumulation in obese rats.
    Miotto PM, Horbatuk M, Proudfoot R, Matravadia S, Bakovic M, Chabowski A, Holloway GP.
    Am J Physiol Endocrinol Metab; 2017 Jun 01; 312(6):E461-E470. PubMed ID: 28270444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.